By 2032, it is anticipated that the market for kinase inhibitors used to treat cancer would be worth US$ 122,133.64 million. As of 2022, the market had a value of $45,000 million, and it was projected to expand at a CAGR of 10.5% during the following five years. Pharmaceutical companies are currently spending a lot of money on research and development to create improved kinase inhibitors. This...